Prosight Management, Lp Top Holdings and 13F Report (2026) About Prosight Management, LpInvestment ActivityProsight Management, Lp has $580.35 million in total holdings as of June 30, 2026.Prosight Management, Lp owns shares of 36 different stocks, but just 13 companies or ETFs make up 80% of its holdings.Approximately 28.49% of the portfolio was purchased this quarter.About 33.59% of the portfolio was sold this quarter.This quarter, Prosight Management, Lp has purchased 46 new stocks and bought additional shares in 16 stocks.Prosight Management, Lp sold shares of 15 stocks and completely divested from 15 stocks this quarter.Largest Holdings LAKEFRONT BIOTHERAPEUTICS NV $61,259,453Janux Therapeutics $58,436,828NEKTAR THERAPEUTICS $56,546,100Boston Scientific $54,215,252Shattuck Labs $41,347,666 Largest New Holdings this Quarter 457669307 - Insmed $40,047,432 Holding603170101 - Mineralys Therapeutics $12,135,469 Holding68404L201 - Option Care Health $5,676,915 Holding717081103 - Pfizer $3,259,613 Holding00191U102 - EVERFORTH INC $1,206,225 Holding Largest Purchases this Quarter Insmed 375,609 shares (about $40.05M)Boston Scientific 474,726 shares (about $20.26M)iRhythm Technologies 155,500 shares (about $18.50M)LAKEFRONT BIOTHERAPEUTICS NV 493,344 shares (about $14.79M)Mineralys Therapeutics 449,795 shares (about $12.14M) Largest Sales this Quarter PROCEPT BioRobotics 1,676,731 shares (about $37.86M)MeiraGTx 2,539,971 shares (about $34.32M)GeneDx 437,963 shares (about $30.07M)Kura Oncology 1,334,736 shares (about $14.64M)Alkermes 119,243 shares (about $6.25M) Sector Allocation Over TimeMap of 500 Largest Holdings ofProsight Management, Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorLAKEFRONT BIOTHERAPEUTICS NV$61,259,453$14,790,453 â–²31.8%2,043,34410.6%SPON ADRJANXJanux Therapeutics$58,436,828$3,908,828 â–²7.2%3,804,48110.1%HealthcareNEKTAR THERAPEUTICS$56,546,100$5,235,750 â–²10.2%810,0009.7%COM NEWBSXBoston Scientific$54,215,252$20,261,306 â–²59.7%1,270,2739.3%HealthcareSTTKShattuck Labs$41,347,666$6,616,860 â–²19.1%5,957,8777.1%HealthcareINSMInsmed$40,047,432$40,047,432 â–²New Holding375,6096.9%HealthcareALNYAlnylam Pharmaceuticals$29,525,022$6,646,742 â–²29.1%98,0805.1%HealthcareSNDXSyndax Pharmaceuticals$26,232,000$9,399,800 â–²55.8%1,200,0004.5%HealthcareKURAKura Oncology$22,180,945$14,642,054 â–¼-39.8%2,021,9643.8%HealthcareALKSAlkermes$20,664,012$6,247,737 â–¼-23.2%394,3893.6%HealthcareIRTCiRhythm Technologies$19,686,225$18,496,725 â–²1,555.0%165,5003.4%HealthcareVEEVVeeva Systems$18,847,314$3,499,708 â–²22.8%106,2003.2%HealthcareZYMEWORKS INC$17,629,705$3,538,964 â–²25.1%674,4343.0%COMABIVAX SA$14,311,324$319,024 â–²2.3%107,3942.5%SPONSORED ADSCRNXCrinetics Pharmaceuticals$14,020,002$923,002 â–²7.0%374,6662.4%HealthcareMLYSMineralys Therapeutics$12,135,469$12,135,469 â–²New Holding449,7952.1%HealthcareADCTADC Therapeutics$8,372,481$508,519 â–¼-5.7%7,824,7491.4%HealthcareICUIICU Medical$7,476,600$3,452,430 â–²85.8%51,0001.3%HealthcareISRGIntuitive Surgical$6,760,560$5,169,840 â–²325.0%17,0001.2%HealthcareCRBPCorbus Pharmaceuticals$6,097,000$441,873 â–¼-6.8%650,0001.1%HealthcarePRCTPROCEPT BioRobotics$6,057,514$37,860,586 â–¼-86.2%268,2691.0%HealthcareWGSGeneDx$5,869,575$30,066,160 â–¼-83.7%85,5001.0%HealthcareOPCHOption Care Health$5,676,915$5,676,915 â–²New Holding270,7161.0%HealthcareONKURE THERAPEUTICS INC$4,464,204$5,359,774 â–¼-54.6%978,9920.8%COM CL AEBSEmergent Biosolutions$3,854,398$1,501,411 â–¼-28.0%459,9520.7%HealthcarePFEPfizer$3,259,613$3,259,613 â–²New Holding135,3660.6%HealthcareKIDSOrthoPediatrics$3,012,975$2,771,918 â–¼-47.9%157,5000.5%HealthcareRCKTRocket Pharmaceuticals$2,394,000$55,212 â–²2.4%700,0000.4%HealthcareAN2 THERAPEUTICS INC$2,297,248$199,001 â–¼-8.0%474,6380.4%COMPLRXPliant Therapeutics$1,562,066$338,998 â–¼-17.8%1,370,2330.3%HealthcareTECTONIC THERAPEUTIC INC$1,365,753$1,379,847 â–¼-50.3%39,7310.2%COMMGTXMeiraGTx$1,215,900$34,315,008 â–¼-96.6%90,0000.2%HealthcareEVERFORTH INC$1,206,225$1,206,225 â–²New Holding67,5000.2%COMREIN THERAPEUTICS INC$1,144,000$715,936 â–²167.2%1,100,0000.2%COM NEWCOYACoya Therapeutics$994,500$1,464,606 â–¼-59.6%170,0000.2%HealthcareIMRXImmuneering$183,936$431,874 â–¼-70.1%36,8610.0%HealthcareCONCENTRA GROUP HOLDINGS PAR$0$10,849,882 â–¼-100.0%00.0%COMMON STOCKTERNTerns Pharmaceuticals$0$10,665,256 â–¼-100.0%00.0%HealthcarePHRPhreesia$0$9,218,000 â–¼-100.0%00.0%HealthcareSDGRSchrodinger$0$5,800,166 â–¼-100.0%00.0%HealthcareROIVRoivant Sciences$0$4,986,000 â–¼-100.0%00.0%HealthcareIMVTImmunovant$0$4,367,493 â–¼-100.0%00.0%HealthcareUPSTREAM BIO INC$0$2,170,107 â–¼-100.0%00.0%COMOMEROmeros$0$1,845,888 â–¼-100.0%00.0%HealthcareADICET BIO INC$0$1,704,162 â–¼-100.0%00.0%COM NEWRGNXREGENXBIO$0$1,676,000 â–¼-100.0%00.0%HealthcareVKTXViking Therapeutics$0$1,464,300 â–¼-100.0%00.0%HealthcareTBITrueBlue$0$974,008 â–¼-100.0%00.0%IndustrialsPALVELLA THERAPEUTICS INC NE$0$623,250 â–¼-100.0%00.0%COMNVCRNovoCure$0$549,360 â–¼-100.0%00.0%HealthcareTMDXTransMedics Group$0$497,050 â–¼-100.0%00.0%HealthcareShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
